HealthEquity Cash And Short Term Investments from 2010 to 2024
| HQY Stock | USD 81.68 2.56 3.24% |
Cash And Short Term Investments | First Reported 2014-01-31 | Previous Quarter 334.1 M | Current Value 404 M | Quarterly Volatility 185.3 M |
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many exotic indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.76. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
HealthEquity | Cash And Short Term Investments |
Latest HealthEquity's Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of HealthEquity over the last few years. Short Term Investments is an account in the current assets section of HealthEquity balance sheet. This account contains HealthEquity investments that will expire within one year. These investments include stocks and bonds that can be liquidated by HealthEquity fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. HealthEquity's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
HealthEquity Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 181,349,187 | |
| Geometric Mean | 107,280,526 | |
| Coefficient Of Variation | 72.03 | |
| Mean Deviation | 106,484,974 | |
| Median | 191,726,000 | |
| Standard Deviation | 130,616,821 | |
| Sample Variance | 17060.8T | |
| Range | 390.1M | |
| R-Value | 0.85 | |
| Mean Square Error | 5043.6T | |
| R-Squared | 0.73 | |
| Significance | 0.000056 | |
| Slope | 24,877,106 | |
| Total Sum of Squares | 238850.6T |
HealthEquity Cash And Short Term Investments History
About HealthEquity Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include HealthEquity income statement, its balance sheet, and the statement of cash flows. HealthEquity investors use historical funamental indicators, such as HealthEquity's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although HealthEquity investors may use each financial statement separately, they are all related. The changes in HealthEquity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on HealthEquity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on HealthEquity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 404 M | 243.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:Check out the analysis of HealthEquity Correlation against competitors. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.